AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Price: 130.24 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 14, 2024 | 129.78 | 132.78 | 129.70 | 130.24 | 1696.00 |
| Nov 13, 2024 | 129.20 | 129.20 | 129.20 | 129.20 | 2353.00 |
| Nov 12, 2024 | 126.09 | 129.92 | 126.09 | 128.41 | 1186.00 |
| Nov 11, 2024 | 124.68 | 126.80 | 124.68 | 126.80 | 2372.00 |
| Nov 08, 2024 | 128.52 | 130.06 | 123.85 | 127.74 | 2595.00 |
| Nov 07, 2024 | 126.32 | 126.56 | 121.31 | 126.56 | 2119.00 |
| Nov 06, 2024 | 128.00 | 128.00 | 125.90 | 126.54 | 1704.00 |
| Nov 05, 2024 | 137.10 | 137.10 | 130.33 | 131.04 | 2271.00 |
| Nov 04, 2024 | 142.20 | 143.11 | 141.42 | 142.43 | 1212.00 |
| Nov 01, 2024 | 142.20 | 142.85 | 142.20 | 142.85 | 775.00 |
| Oct 31, 2024 | 142.90 | 144.05 | 141.90 | 141.90 | 1307.00 |
| Oct 30, 2024 | 143.80 | 149.50 | 143.00 | 149.50 | 5048.00 |
| Oct 29, 2024 | 149.65 | 149.65 | 149.65 | 149.65 | 500.00 |
| Oct 28, 2024 | 148.60 | 148.60 | 148.60 | 148.60 | 0.000 |
| Oct 25, 2024 | 148.60 | 148.60 | 148.60 | 148.60 | 1193.00 |
| Oct 24, 2024 | 152.50 | 152.50 | 151.70 | 151.70 | 930.00 |
| Oct 23, 2024 | 157.15 | 157.15 | 152.34 | 152.34 | 1553.00 |
| Oct 22, 2024 | 152.52 | 156.40 | 152.52 | 156.40 | 1310.00 |
| Oct 21, 2024 | 153.62 | 154.64 | 153.62 | 154.64 | 847.00 |
| Oct 18, 2024 | 155.38 | 157.88 | 155.38 | 157.88 | 622.00 |
| Oct 17, 2024 | 154.60 | 154.60 | 154.52 | 154.52 | 1222.00 |
| Oct 16, 2024 | 153.70 | 153.70 | 153.70 | 153.70 | 0.000 |
| Oct 15, 2024 | 153.70 | 153.70 | 153.70 | 153.70 | 484.00 |
| Oct 14, 2024 | 147.37 | 147.37 | 147.37 | 147.37 | 0.000 |
| Oct 11, 2024 | 147.37 | 147.37 | 147.37 | 147.37 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
76.00
Minimum
Mar 13 2020
175.00
Maximum
Aug 30 2024
123.41
Average
122.86
Median
Price Benchmarks
| Adaptimmune Therapeutics PLC | 0.5912 |
| Biodexa Pharmaceuticals PLC | 4.86 |
| Verona Pharma PLC | 35.37 |
| NuCana PLC | 1.55 |
| Autolus Therapeutics PLC | 3.01 |
Price Related Metrics
| PE Ratio | 31.46 |
| PS Ratio | 4.140 |
| PEG Ratio | 6.921 |
| Price to Book Value | 5.110 |
| Price to Free Cash Flow | 29.20 |
| Earnings Yield | 3.18% |
| Market Cap | 201.91B |
| PEGY Ratio | 4.604 |
| Operating PE Ratio | 20.72 |
| Normalized PE Ratio | 28.83 |